U.K. Tobacco Giant Gets Medicinal Cannabis Expertise

  • Simon Langelier chairs a Canadian medicinal marijuana company
  • Langelier headed Philip Morris’s next-generation products unit
Photographer: David Ryder/Bloomberg
Lock
This article is for subscribers only.

Imperial Brands Plc gained the services of a leader in the field of medicinal cannabis as the British tobacco manufacturer seeks to further its push beyond cigarettes.

Simon Langelier, a 30-year veteran of Philip Morris International Inc., joined the board as a non-executive director this week, the Bristol-based company said in a statement Tuesday.